Drug Policy in the European Union

Author(s):  
Caroline Chatwin
2013 ◽  
Vol 54 (1) ◽  
pp. 3-28
Author(s):  
Mike Vuolo

This article addresses whether state-level policy differences in the European Union (EU) are associated with young people’s support for policies toward drug users, namely criminalization of drug use and availability of syringe exchanges. While historical institutionalism provides reason to expect such an association, more proximal individual-level influences, as well as the EU supranational agenda encouraging a unified approach to drug policy, may render the state-level unimportant. Using multilevel modeling of a 2002 Eurobarometer cross-national survey of young people, the results show a close alignment of individual-level support and state-level policies of decriminalization and harm reduction, net of individual characteristics. The findings suggest that any EU-level effort to unify countries’ policies concerning drug users will encounter difficulty because attitudes – even among young people – are aligned with and supportive of existing state policies.


1998 ◽  
Vol 15 (5-6) ◽  
pp. 262-277
Author(s):  
Svanaug Fjær

Svanaug Fjær: The European Union and Drug Policy. Integration through control and production of knowledge In this article the influence of EU initiatives on national drug policies is discussed with special attention paid to the separation between control and prevention in drug policy. At national levels, policy administration is separated between the ministries responsible for treatment and prevention and the ministries responsible for control and punishment. This separation is parallel to the division established by the pillar structure of the Treaty of the European Union. A study of the Europeanization processes at the central administration level in Sweden, Denmark and the Netherlands showed that the growth in co-operative activity in the EU has been largest in the Ministries of Justice, while, due to establishment of focal points in the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the growth in the health sector has happened in administrative bodies outside of the ministries. The networks which are developed and the means available are different in the justice and health sectors. In the third pillar (justice), practical and technical cooperation have developed in the form of EUROPOL and the Early Warning System on Synthetic Drugs. Sharing of information and the development of a common knowledge-base seems to be the basis of first-pillar (health) cooperation. In the three countries studied the Ministries of Health, which traditionally have had a central position at the national level, seem to have been allotted a less important role in the international co-operation. It is, however, argued that the impact of co-operation in the EM-CDDA should not be underestimated. Both common control and the development of a European base of knowledge contribute to the integration process in the drug field, but the premises for the process are set by the demand for control.


Sign in / Sign up

Export Citation Format

Share Document